References analysis of the Wikipedia article "Flecainide" in the English version

doi.org (Global: 2^nd place; English: 2^nd place)

Gill JS, Mehta D, Ward DE, Camm AJ (October 1992). "Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality". British Heart Journal. 68 (4): 392–397. doi:10.1136/hrt.68.10.392. PMC 1025139. PMID 1449923.

Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. (March 1991). "Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial". The New England Journal of Medicine. 324 (12): 781–788. doi:10.1056/NEJM199103213241201. PMID 1900101.

Greenberg HM, Dwyer EM, Hochman JS, Steinberg JS, Echt DS, Peters RW (December 1995). "Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I". British Heart Journal. 74 (6): 631–635. doi:10.1136/hrt.74.6.631. PMC 484119. PMID 8541168.

Aliot E, Capucci A, Crijns HJ, Goette A, Tamargo J (February 2011). "Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation". Europace. 13 (2): 161–173. doi:10.1093/europace/euq382. PMC 3024037. PMID 21138930.

Gasparini M, Priori SG, Mantica M, Napolitano C, Galimberti P, Ceriotti C, et al. (January 2003). "Flecainide test in Brugada syndrome: a reproducible but risky tool". Pacing and Clinical Electrophysiology. 26 (1P2): 338–341. doi:10.1046/j.1460-9592.2003.00045.x. PMID 12687841. S2CID 555793.

Cardiac Arrhythmia Suppression Trial (CAST) Investigators (August 1989). "Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction". The New England Journal of Medicine. 321 (6): 406–412. doi:10.1056/NEJM198908103210629. PMID 2473403.

Ohki R, Takahashi M, Mizuno O, Fujikawa H, Mitsuhashi T, Katsuki T, et al. (January 2001). "Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia". Pacing and Clinical Electrophysiology. 24 (1): 119–121. doi:10.1046/j.1460-9592.2001.00119.x. PMID 11227957. S2CID 41090195.

Morganroth J (February 1992). "Early and late proarrhythmia from antiarrhythmic drug therapy". Cardiovascular Drugs and Therapy. 6 (1): 11–14. doi:10.1007/BF00050910. PMID 1533532. S2CID 22653784.

Santinelli V, Arnese M, Oppo I, Matarazzi C, Maione S, Palma M, et al. (April 1993). "Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function". Chest. 103 (4): 1068–1073. doi:10.1378/chest.103.4.1068. PMID 8131440.

Fornieles-Pérez H, Montoya-García M, Levine PA, Sanz O (May 2002). "Documentation of acute rise in ventricular capture thresholds associated with flecainide acetate". Pacing and Clinical Electrophysiology. 25 (5): 871–872. doi:10.1046/j.1460-9592.2002.00871.x. PMID 12049386. S2CID 7180036.

Suffredini JM, Rutland J, Akpunonu P, Baum R, Catanzaro J, Elayi CS (August 2019). "Flecainide Toxicity Resulting in Pacemaker Latency and Intermittent Failure to Capture". The American Journal of Case Reports. 20: 1279–1283. doi:10.12659/AJCR.916370. PMC 6735620. PMID 31467262.

Winkelmann BR, Leinberger H (June 1987). "Life-threatening flecainide toxicity. A pharmacodynamic approach". Annals of Internal Medicine. 106 (6): 807–814. doi:10.7326/0003-4819-106-6-807. PMID 3107447.

Corkeron MA, van Heerden PV, Newman SM, Dusci L (August 1999). "Extracorporeal circulatory support in near-fatal flecainide overdose". Anaesthesia and Intensive Care. 27 (4): 405–408. doi:10.1177/0310057x9902700413. PMID 10470398.

Yasui RK, Culclasure TF, Kaufman D, Freed CR (May 1997). "Flecainide overdose: is cardiopulmonary support the treatment?". Annals of Emergency Medicine. 29 (5): 680–682. doi:10.1016/S0196-0644(97)70257-9. PMID 9140253.

Latini R, Cavalli A, Maggioni AP, Volpi A (December 1987). "Flecainide distribution in human tissues". British Journal of Clinical Pharmacology. 24 (6): 820–822. doi:10.1111/j.1365-2125.1987.tb03252.x. PMC 1386410. PMID 3125854.

Ozkan M, Dweik RA, Ahmad M (September 2001). "Drug-induced lung disease". Cleveland Clinic Journal of Medicine. 68 (9): 782–785, 789–795. doi:10.3949/ccjm.68.9.782 (inactive 1 July 2025). PMID 11563482. S2CID 45036873.{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link)

Camus P, Fanton A, Bonniaud P, Camus C, Foucher P (2004). "Interstitial lung disease induced by drugs and radiation". Respiration; International Review of Thoracic Diseases. 71 (4): 301–326. doi:10.1159/000079633. PMID 15316202. S2CID 16315007.

Pesenti S, Lauque D, Daste G, Boulay V, Pujazon MC, Carles P (2002). "Diffuse infiltrative lung disease associated with flecainide. Report of two cases". Respiration; International Review of Thoracic Diseases. 69 (2): 182–185. doi:10.1159/000056325. PMID 11961436. S2CID 72367121.

Robain A, Perchet H, Fuhrman C (February 2000). "Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome". Acta Cardiologica. 55 (1): 45–47. doi:10.2143/ac.55.1.2005718. PMID 10707759. S2CID 20721407.

Smith GH (October 1985). "Flecainide: a new class Ic antidysrhythmic". Drug Intelligence & Clinical Pharmacy. 19 (10): 703–707. doi:10.1177/106002808501901001. PMID 3902429. S2CID 1086493.

Padrini R, Piovan D, Busa M, al-Bunni M, Maiolino P, Ferrari M (January 1993). "Pharmacodynamic variability of flecainide assessed by QRS changes". Clinical Pharmacology and Therapeutics. 53 (1): 59–64. doi:10.1038/clpt.1993.9. PMID 8422742. S2CID 23471140.

Haefeli WE, Bargetzi MJ, Follath F, Meyer UA (May 1990). "Potent inhibition of cytochrome P450IID6 (debrisoquin 4-hydroxylase) by flecainide in vitro and in vivo". Journal of Cardiovascular Pharmacology. 15 (5): 776–779. doi:10.1097/00005344-199005000-00013. PMID 1692938. S2CID 25544471.

Ghannam A, Tazi A, Kettani A, Faroudy M (2014). "Non-Accidental Flecainide Overdose, A Case Report". International Journal of Medicine and Surgery. 1 (2): 53. doi:10.15342/ijms.v1i2.18.

Ramos E, O'leary ME (October 2004). "State-dependent trapping of flecainide in the cardiac sodium channel". The Journal of Physiology. 560 (Pt 1): 37–49. doi:10.1113/jphysiol.2004.065003. PMC 1665201. PMID 15272045.

Wang Z, Fermini B, Nattel S (November 1993). "Mechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue". The Journal of Pharmacology and Experimental Therapeutics. 267 (2): 575–581. doi:10.1016/S0022-3565(25)39407-3. PMID 8246130.

Mehra D, Imtiaz MS, van Helden DF, Knollmann BC, Laver DR (December 2014). "Multiple modes of ryanodine receptor 2 inhibition by flecainide". Molecular Pharmacology. 86 (6): 696–706. doi:10.1124/mol.114.094623. PMC 4244595. PMID 25274603.

Hilliard FA, Steele DS, Laver D, Yang Z, Le Marchand SJ, Chopra N, et al. (February 2010). "Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass". Journal of Molecular and Cellular Cardiology. 48 (2): 293–301. doi:10.1016/j.yjmcc.2009.10.005. PMC 2813417. PMID 19835880.

Smith GL, MacQuaide N (April 2015). "The direct actions of flecainide on the human cardiac ryanodine receptor: keeping open the debate on the mechanism of action of local anesthetics in CPVT". Circulation Research. 116 (8): 1284–1286. doi:10.1161/CIRCRESAHA.115.306298. PMID 25858058.

drugs.com (Global: 399^th place; English: 333^rd place)

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Sakurada H, Hiyoshi Y, Tejima T, Yanase O, Tokuyasu Y, Watanabe K, et al. (May 1990). "[Effects of oral flecainide treatment of refractory tachyarrhythmias]". Kokyu to Junkan. Respiration & Circulation. 38 (5): 471–476. PMID 2115193.

Haas M, Pérault MC, Bonnefoy P, Rodeau F, Caron F (2001). "[Interstitial pneumopathy due to flecainide]". Presse Médicale. 30 (21): 1062. PMID 11471279.

Smith GH (October 1985). "Flecainide: a new class Ic antidysrhythmic". Drug Intelligence & Clinical Pharmacy. 19 (10): 703–707. doi:10.1177/106002808501901001. PMID 3902429. S2CID 1086493.

ncbi.nlm.nih.gov

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Smith GH (October 1985). "Flecainide: a new class Ic antidysrhythmic". Drug Intelligence & Clinical Pharmacy. 19 (10): 703–707. doi:10.1177/106002808501901001. PMID 3902429. S2CID 1086493.

Flecainide (English Wikipedia)

clincalc.com (Global: 3,912^th place; English: 2,496^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

drugs.com (Global: 399^th place; English: 333^rd place)

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

web.archive.org (Global: 1^st place; English: 1^st place)

Flecainide (English Wikipedia)

clincalc.com (Global: 3,912th place; English: 2,496th place)

doi.org (Global: 2nd place; English: 2nd place)

drugs.com (Global: 399th place; English: 333rd place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

web.archive.org (Global: 1st place; English: 1st place)

clincalc.com (Global: 3,912^th place; English: 2,496^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

drugs.com (Global: 399^th place; English: 333^rd place)

nih.gov (Global: 4^th place; English: 4^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

web.archive.org (Global: 1^st place; English: 1^st place)